Who could replace Palantir in the NHS?
THE SO WHAT
The search for a Palantir alternative inside the NHS is a live test of whether health systems will tolerate lock-in or push for more modular, sovereign data platforms. If you sell into public healthcare, expect procurement to probe harder on data residency, interoperability, and exit options — and tune your offer accordingly.
READ THE SOURCE
MORE FROM THE WIRE
Deep & Emerging TechChinese Flash Memory Giant YMTC Said to Target IPO in Early 2027
A YMTC IPO on Shanghai in early 2027 would deepen China’s domestic NAND capital base just as AI and edge workloads spike storage demand. If you depend on US or Korean flash, start modeling a world where Chinese capacity is less accessible due to geopolitics yet more competitive on price in neutral markets.
Deep & Emerging TechThe Nvidia spy scandal exposes networks operating in Singapore that help Chinese tech companies access advanced US AI chips and circumvent export controls
Networks in Singapore allegedly helping Chinese firms route around US AI chip controls show how export regimes are colliding with real-world demand for compute. If you operate in or ship through these hubs, expect tighter compliance scrutiny and treat sanctions exposure as a board-level risk, not a legal footnote.
Deep & Emerging TechSouth Korean Battery Makers Face Greater Scrutiny in Hungary
Hungary turning up regulatory scrutiny on SK On and Samsung SDI after billions invested shows how host countries are re-pricing the externalities of EV supply chains. If you’re siting battery or materials plants in Europe, assume permitting, labor, and environmental reviews will tighten mid-project and bake that into timelines.
Deep & Emerging TechSources: Rapidus has yet to produce functioning SRAM, a key step that needed to be completed by summer 2026 to meet its March 2028 deadline for making 2nm chips
Rapidus missing its SRAM milestone for 2nm by summer 2026 is a concrete sign that catching TSMC and Samsung on leading-edge logic is harder than subsidy math suggests. If your national or corporate strategy leans on new entrants for advanced nodes by 2028, downgrade those assumptions and secure alternative capacity now.